Table 2.
Comparing factors associated with adherence to anti-retroviral therapy, in Fars province, 2014
| Variables | Group | Statistical index | p-value | ||
| Non-adherence | Adherence | ||||
| Travelling time to the center | 54.38 ± 58.9 | 70.5 (83.26) | T=1.608 | 0.110* | |
| Mode of HIV transmission |
Drug injection (n=43) |
24(38.1) | 19 (12.9) | X2 = 23.8 | <0.001* |
| Sexual contact (n=18) |
3 (4.8) | 15 (10.2) | |||
| Drug injection and sexual contact (n=82) |
26 (41.3) | 56 (38.1) | |||
| Spouse of the patient (n=52) |
6 (9.5) | 46 (31.3) | |||
| Other (n=15) | 4 (6.3) | 11 (7.5) | |||
| Hospitalization | Yes (n=116) | 41 (66.1) | 75 (50.7) | X2=4.22 | 0.040* |
| No (n=194) | 21 (33.9) | 73 (49.3) | |||
| Assistance in drug consumption |
Family (n=66) | 26 (39.4) | 40 (60.6) | X2=5.2 | 0.074 |
| Patient (n=132) | 35 (26.5) | 97 (73.5) | |||
| Family and patient (n=14) |
2 (14.3) | 12 (85.7) | |||
| Access to regular food |
Yes (n=168) | 53 (81.5) | 115 (78.2) | X2 = 0.3 | 0.584 |
| No (n=44) | 12 (18.5) | 32 (21.8) | |||
| Methadone consumption |
Yes (n=69) | 40 (61.5) | 29 (21) | X2=32.34 | <0.001* |
| No (n=134) | 25 (38.5) | 109 (79) | |||
| CD4 | 163.74±226.77 | 202.1±326.55 | t=3.5 | <0.001* | |
| BMI | 22.26±4.9 | 23.32±4.1 | T=1.57 | 0.116 | |
| Clinical staging | 1(n=86) | 21 (32.3) | 65 (43.9) | X2=5.49 | 0.139 |
| 2(n=85) | 54 (36.5) | 31 (47.7) | |||
| 3(n=37) | 24 (16.2) | 13 (20) | |||
| 4(n=5) | 0 (0) | 5 (3.4) | |||
| Social support score | 29.3±4.6 | 28.40±3.58 | X2=1.51 | 0.132 | |
*
Statistically significant